Nov 21, 2011 6:05am EST TONIX Pharmaceuticals to Present at the New York Society of Security Analysts’ 15th Annual Biotech and Specialty Pharmaceuticals Conference on November 30, 2011
Nov 18, 2011 7:30am EST Tonix Pharmaceuticals Receives FDA Clearance to Initiate a Pharmacokinetic Study of TNX-102 For Fibromyalgia
Oct 20, 2011 9:00am EDT Tamandare Explorations Inc. Announces Name Change to Tonix Pharmaceuticals Holding Corp.
Oct 14, 2011 9:00am EDT TONIX Pharmaceuticals and Tamandare Explorations Announce Completion of Share Exchange Transaction and Private Placement
Sep 7, 2011 9:00am EDT Tonix Pharmaceuticals' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology
Jun 20, 2011 9:00am EDT Tonix Pharmaceuticals Elects Harvey Moldofsky, M.D., to its Scientific Advisory Board
Jun 16, 2011 9:00am EDT TONIX Pharmaceuticals Presents Findings on the Effects of Bedtime Very Low Dose (VLD) Cyclobenzaprine (CBP) on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome
Nov 9, 2010 9:00am EST TONIX Pharmaceuticals Reports Analysis of Phase 2a Study of Very Low Dosage Cyclobenzaprine in Fibromyalgia Syndrome (FMS)
